DK0994115T3 - Fremgangsmåde til fremstilling af pyrazolo-(4,3-d)pyrimidin-7-oner og mellemprodukter deraf - Google Patents

Fremgangsmåde til fremstilling af pyrazolo-(4,3-d)pyrimidin-7-oner og mellemprodukter deraf

Info

Publication number
DK0994115T3
DK0994115T3 DK99307996T DK99307996T DK0994115T3 DK 0994115 T3 DK0994115 T3 DK 0994115T3 DK 99307996 T DK99307996 T DK 99307996T DK 99307996 T DK99307996 T DK 99307996T DK 0994115 T3 DK0994115 T3 DK 0994115T3
Authority
DK
Denmark
Prior art keywords
pyrazolo
pyrimidin
intermediates
ones
preparation
Prior art date
Application number
DK99307996T
Other languages
Danish (da)
English (en)
Inventor
Peter James Dunn
Philip Charles Levett
Original Assignee
Pfizer Overseas Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0994115(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Overseas Pharmaceutical filed Critical Pfizer Overseas Pharmaceutical
Application granted granted Critical
Publication of DK0994115T3 publication Critical patent/DK0994115T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99307996T 1998-10-12 1999-10-11 Fremgangsmåde til fremstilling af pyrazolo-(4,3-d)pyrimidin-7-oner og mellemprodukter deraf DK0994115T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
EP99307996A EP0994115B1 (en) 1998-10-12 1999-10-11 Process for preparation of pyrazolo-(4,3-d)pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
DK0994115T3 true DK0994115T3 (da) 2005-06-20

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99307996T DK0994115T3 (da) 1998-10-12 1999-10-11 Fremgangsmåde til fremstilling af pyrazolo-(4,3-d)pyrimidin-7-oner og mellemprodukter deraf

Country Status (48)

Country Link
US (3) US6207829B1 (cs)
EP (1) EP0994115B1 (cs)
JP (1) JP3721021B2 (cs)
KR (1) KR100380954B1 (cs)
CN (2) CN1207295C (cs)
AP (1) AP1233A (cs)
AR (1) AR019244A1 (cs)
AT (1) ATE290003T1 (cs)
AU (1) AU756463B2 (cs)
BG (1) BG63205B1 (cs)
BR (1) BR9905092A (cs)
CA (1) CA2285733C (cs)
CO (1) CO5150214A1 (cs)
CR (1) CR6118A (cs)
CU (1) CU22928A3 (cs)
CZ (1) CZ296816B6 (cs)
DE (1) DE69923906T2 (cs)
DK (1) DK0994115T3 (cs)
DZ (1) DZ2912A1 (cs)
EA (1) EA003774B1 (cs)
EE (1) EE04192B1 (cs)
EG (1) EG22630A (cs)
ES (1) ES2237049T3 (cs)
GB (1) GB9822238D0 (cs)
GE (1) GEP20022700B (cs)
GT (1) GT199900172A (cs)
HR (1) HRP990318B1 (cs)
HU (1) HU226162B1 (cs)
ID (1) ID23351A (cs)
IL (11) IL132273A (cs)
IS (1) IS1951B (cs)
MA (1) MA25007A1 (cs)
MY (1) MY124620A (cs)
NO (1) NO313700B1 (cs)
OA (1) OA11165A (cs)
PE (1) PE20001086A1 (cs)
PL (1) PL198150B1 (cs)
PT (1) PT994115E (cs)
RS (1) RS49762B (cs)
SG (1) SG118060A1 (cs)
SI (1) SI0994115T1 (cs)
SK (1) SK285215B6 (cs)
TN (1) TNSN99189A1 (cs)
TR (1) TR199902541A2 (cs)
TW (1) TW589314B (cs)
UA (1) UA66787C2 (cs)
UY (1) UY25750A1 (cs)
ZA (1) ZA996412B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5204800A (en) * 1999-06-21 2001-01-09 Biochemical Pharmaceutical Factory of Zhuhai Sez, The Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
BR0111581A (pt) * 2000-06-22 2003-03-25 Pfizer Processos para a preparação de pirazolopirimidinonas
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
EP1176147A1 (en) * 2000-07-28 2002-01-30 Pfizer Limited Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
WO2003053923A2 (en) * 2001-12-20 2003-07-03 Applied Research Systems Ars Holding N.V. Pyrrolidine derivatives as prostaglandin modulators
US6908923B2 (en) 2001-12-21 2005-06-21 Cytokinetics, Inc. Compositions and methods for treating heart failure
EP1719772A1 (en) 2002-05-31 2006-11-08 Schering Corporation Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
WO2004086865A1 (en) 2003-03-27 2004-10-14 Cytokinetics, Inc. Compounds, compositions and methods
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
WO2007141805A2 (en) * 2006-06-05 2007-12-13 Matrix Laboratories Limited Novel process for the preparation of sildenafil citrate
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
CN1281588C (zh) * 1997-04-25 2006-10-25 美国辉瑞有限公司 制备吡唑并嘧啶酮类化合物的新型中间体

Also Published As

Publication number Publication date
JP2000119273A (ja) 2000-04-25
DZ2912A1 (fr) 2004-03-01
HK1027559A1 (en) 2001-01-19
IL152928A0 (en) 2003-06-24
CN1255497A (zh) 2000-06-07
IL152924A0 (en) 2003-06-24
MY124620A (en) 2006-06-30
PE20001086A1 (es) 2000-10-18
SG118060A1 (en) 2006-01-27
CA2285733C (en) 2004-08-24
CN1207295C (zh) 2005-06-22
HUP9903469A3 (en) 2000-10-30
PL198150B1 (pl) 2008-05-30
CZ353299A3 (cs) 2000-05-17
MA25007A1 (fr) 2000-07-01
CA2285733A1 (en) 2000-04-12
AU5358199A (en) 2000-04-13
US20030069422A1 (en) 2003-04-10
KR100380954B1 (ko) 2003-04-21
IL152924A (en) 2004-02-19
SI0994115T1 (cs) 2005-08-31
EP0994115A2 (en) 2000-04-19
HRP990318B1 (en) 2004-06-30
BG63205B1 (bg) 2001-06-29
IL152923A0 (en) 2003-06-24
DE69923906T2 (de) 2006-04-06
EG22630A (en) 2003-05-31
NO994943D0 (no) 1999-10-11
OA11165A (en) 2003-04-22
TNSN99189A1 (fr) 2005-11-10
CU22928A3 (es) 2004-02-20
TW589314B (en) 2004-06-01
PL335959A1 (en) 2000-04-25
US6207829B1 (en) 2001-03-27
IL152926A0 (en) 2003-06-24
JP3721021B2 (ja) 2005-11-30
DE69923906D1 (de) 2005-04-07
HU9903469D0 (en) 1999-12-28
EA199900822A2 (ru) 2000-04-24
HUP9903469A2 (hu) 2000-08-28
AR019244A1 (es) 2001-12-26
HRP990318A2 (en) 2000-06-30
ZA996412B (en) 2001-04-11
NO994943L (no) 2000-04-13
EE9900507A (et) 2000-06-15
AP1233A (en) 2003-12-18
IS1951B (is) 2004-10-13
EP0994115A3 (en) 2000-05-24
SK138599A3 (en) 2000-05-16
BR9905092A (pt) 2000-08-08
GEP20022700B (en) 2002-05-27
SK285215B6 (sk) 2006-09-07
IL152923A (en) 2004-02-08
CO5150214A1 (es) 2002-04-29
ATE290003T1 (de) 2005-03-15
UA66787C2 (en) 2004-06-15
CN1473831A (zh) 2004-02-11
GB9822238D0 (en) 1998-12-09
CZ296816B6 (cs) 2006-06-14
UY25750A1 (es) 2001-08-27
KR20000028987A (ko) 2000-05-25
GT199900172A (es) 2001-03-28
AU756463B2 (en) 2003-01-16
IL132273A (en) 2004-06-20
YU48999A (sh) 2002-06-19
NO313700B1 (no) 2002-11-18
BG103794A (en) 2000-09-29
EA199900822A3 (ru) 2000-08-28
CR6118A (es) 2005-09-16
ES2237049T3 (es) 2005-07-16
IL152927A (en) 2004-06-01
US20010009962A1 (en) 2001-07-26
PT994115E (pt) 2005-06-30
RS49762B (sr) 2008-04-04
IL132273A0 (en) 2001-03-19
HU226162B1 (en) 2008-05-28
IS5209A (is) 2000-04-13
EA003774B1 (ru) 2003-08-28
IL152926A (en) 2004-02-19
EE04192B1 (et) 2003-12-15
AP9901672A0 (en) 1999-12-31
EP0994115B1 (en) 2005-03-02
IL152928A (en) 2007-07-04
IL152927A0 (en) 2003-06-24
ID23351A (id) 2000-04-13
TR199902541A2 (xx) 2000-07-21

Similar Documents

Publication Publication Date Title
DK0994115T3 (da) Fremgangsmåde til fremstilling af pyrazolo-(4,3-d)pyrimidin-7-oner og mellemprodukter deraf
DK0916675T3 (da) Fremgangsmåde til fremstilling af sildenafil
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
IS5952A (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
DK0756597T3 (da) Fremgangsmåde til fremstilling af puriner
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
IS5654A (is) Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
DK0713879T3 (da) Fremgangsmåde til fremstilling af gangliosid
DK1035098T3 (da) Fremgangsmåde til fremstilling af sorbinsyre
DK0863874T3 (da) Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
DK0711782T3 (da) Fremgangsmåde til fremstilling af gangliosid
DK0621264T3 (da) Fremgangsmåde til fremstilling af arylbenzylethere
DK0729971T3 (da) Fremgangsmåde til fremstilling af ivermectin